Skip to main content
62°
Rain Shower
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
113.09
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
92
93
Next >
FDA Approves Merck's Blockbuster Cancer Drug For Type Of Gastric Cancer
November 17, 2023
The FDA has approved Merck & Co Inc's (NYSE: MRK) Keytruda, an anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing chemotherapy, for the first-line treatment of adults with...
Via
Benzinga
Exposures
Product Safety
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
November 17, 2023
The Delaware Supreme Court reportedly ruled in favor of Bayer AG (OTC: BAYRY) (OTC: BAYZF), stating that the company is not accountable for lawsuits associated with talc-based foot powder products...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
November 17, 2023
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump.
Via
Benzinga
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
November 16, 2023
From
Merck & Co., Inc.
Via
Business Wire
Looking Into Merck & Co's Recent Short Interest
November 10, 2023
Via
Benzinga
10 Analysts Have This to Say About Merck & Co
November 09, 2023
Via
Benzinga
Merck's Gefapixant Under FDA Lens: Advisory Committee To Discuss Chronic Cough Drug's Future
November 16, 2023
The FDA's Pulmonary-Allergy Drugs Advisory Committee
Via
Benzinga
Exposures
Product Safety
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
November 16, 2023
The FDA approved Bristol Myers Squibb And Co's (NYSE: BMY) Augtyro (repotrectinib) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small
Via
Benzinga
Exposures
Product Safety
2 Healthcare Stocks That Could Make You Richer
November 15, 2023
Merck and Intuitive Surgical both still have bright futures ahead.
Via
The Motley Fool
Global Oncology Drugs Market Size Projected to Reach $484 Billion by 2030
November 14, 2023
EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NYSE:BMY),(NYSE:NVS),(NYSE:MRK),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Merck & Co Unusual Options Activity For November 03
November 03, 2023
Via
Benzinga
The 3 Best Defensive Stocks for Uncertain Times
November 13, 2023
These are the best defensive stocks to buy as they represent low beta names and companies with robust fundamentals and cash flows.
Via
InvestorPlace
3 S&P stocks with growth to weather a downturn
November 13, 2023
S&P 500 components Broadcom, McCormick and Merck stocks are diverse stocks worth tracking for investors seeking strong earnings and dividend growth.
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
November 11, 2023
There's a lot more at stake than bragging rights.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
Via
Benzinga
Qualcomm, Merck And 2 Other Stocks Insiders Are Selling
November 10, 2023
The Nasdaq 100 closed lower by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Gemcitabine and Cisplatin as First-Line Treatment for Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
November 10, 2023
From
Merck & Co., Inc.
Via
Business Wire
7 Biotech Stocks to Buy for Big-Time Gains
November 10, 2023
Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.
Via
InvestorPlace
7 Safe Stocks to Buy if You Think Q3’s Gangbuster Growth Won’t Last
November 09, 2023
Although the Q3 U.S. GDP print came in much hotter than expected, the momentum might not last, thus incentivizing safe stocks.
Via
InvestorPlace
BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial
November 08, 2023
BioXcel Therapeutics Inc (NASDAQ: BTAI) announced overall survival (OS) data from its Phase 2 trial of BXCL701 in combination with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) in patients wi
Via
Benzinga
Global Anal Cancer Market Size Expected to Reach $1.24 Billion In 2028 as Treatments Advance
November 09, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:BMY),(NASDAQ:GILD),(NYSE:MRK),(NYSE:PFE) EQNX::TICKER_END
Via
FinancialNewsMedia
Merck to Participate in the Jefferies London Healthcare Conference
November 08, 2023
From
Merck & Co., Inc.
Via
Business Wire
Mizuho's Top Stock Picks For November Revealed
November 05, 2023
As trading for November begins, Mizuho recommends a few stocks for investors to consider.
Via
Benzinga
Down 84% From Its Peak. Is It Finally Time to Buy Moderna?
November 05, 2023
The vaccine developer's huge profits have turned into heavy losses.
Via
The Motley Fool
3 Trustworthy Blue-Chip Stocks to Buy Now
November 04, 2023
Considering the economic and geopolitical uncertainty, seek safety in these blue-chip stocks to buy with earnings and dividend growth.
Via
InvestorPlace
NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Impact of Exclusive Drug-Delivery Solution on GLP-1 Drugs
November 03, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
November 02, 2023
Via
Benzinga
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares
November 02, 2023
The company issued below-consensus sales views for 2023 and 2024.
Via
Investor's Business Daily
3 Dividend Stocks That Could Raise Their Payouts in November
November 02, 2023
Should you add these income-generating stocks to your portfolio?
Via
The Motley Fool
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
November 01, 2023
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic.
Via
Talk Markets
Exposures
COVID-19
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
92
93
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.